Skip to main content
Presentation
View our ESMO GI 2026 presentation by visiting our publications page

Corporate Presentation

Press & Events

Press Releases

July 6, 2026
2026

Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026

Download
June 25, 2026
2026

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026

Download
June 2, 2026
2026

Agenus Announces Virtual 2026 Annual Shareholders Meeting

Download
All Press

Upcoming & Recent Events

June 16, 2026 10:00 AM

Agenus Annual Virtual Shareholder Meeting | 2026

Virtual Meeting
2026
Webcast
March 31, 2026 4:30 PM

Agenus Stakeholder Webcast March 2026 | Access and Execution

Webcast
2026
Webcast
February 7, 2026 5:00 PM

Agenus Stakeholder Webcast January 2026 | Access to Acceleration: Agenus’ BOT+BAL Global Momentum Entering 2026

Webcast
2026
Archive Events
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Annual Virtual Shareholder Meeting | 2026
Date:
June 16, 2026
Time:
10:00 am
Location:
Virtual Meeting
16.06.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Stakeholder Webcast March 2026 | Access and Execution
Date:
March 31, 2026
Time:
4:30 pm
Location:
Webcast
31.03.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file
Add this event to your calendar

Choose a calendar. You’ll be redirected or an .ics file will be downloaded with the event details pre-filled.

Title:
Agenus Stakeholder Webcast January 2026 | Access to Acceleration: Agenus’ BOT+BAL Global Momentum Entering 2026
Date:
February 7, 2026
Time:
5:00 pm
Location:
Webcast
07.02.2026
G
Google Calendar
Opens Google Calendar in a new tab
O
Outlook Calendar
Opens Outlook Calendar
A
Apple Calendar (.ics)
Downloads an ICS file

Investor
Portal

Explore the Agenus investor portal for all information on financials, stock, filings and more.

Visit Investor Portal

Contact Us

Agenus Inc.
investor@agenusbio.com

Quick Links

SEC Filings
Quarterly Results
Annual Reports
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 (781) 674 4400 | F: +1 (781) 674 4200
Our Science
Pipeline
Publications
Clinical Trials
Immunotherapy
About BOT + BAL
Company
Our History
Our Team
Careers
Partners
Access
Patient Access
Contact Medical Affairs
Resources
Press Releases
In the News
Patient Resources
FAQs
Investors
Investor Overview
Events
Financial Information
Opt-out preferencesCookie PolicyTerms and Conditions of UsePrivacy PolicyCommunity GuidelinesAccess to Investigational Medicines PolicyReport Adverse EventInvestor Portal
© 2025 Agenus Inc. All rights reserved.